logo
Military spouse and mom of 5 fights back as vaccine dispute blocks family's permanent change of station

Military spouse and mom of 5 fights back as vaccine dispute blocks family's permanent change of station

Yahoo23-05-2025

Amanda Johnson, a Marine spouse and homeschooling mother of five with a set of twins and a newborn is speaking out after months of what she calls stonewalling by the U.S. military medical establishment.
Her family's upcoming move abroad has been put on hold because their children have not received all the recommended vaccinations despite the Navy's policy stating they're not required. The Marine Corps is interdependent with the Navy for logistical support and medical services through Navy Medical, a sister service in the military.
In an Instagram post by Johnson to her nearly 15,000 followers, one popular commentator summarized the family's situation, writing, "The dark irony of military families being stripped of their freedoms in exchange for their father's sacrifice protecting American freedoms… shameful."
Rep. Sara Jacobs: Military Families Deserve Ivf Coverage And Trump's Support
That post has gone viral among military communities, drawing attention from other spouses, advocacy groups and even congressional offices.
"We were told that our children are not suitable solely based on their vaccination status," Johnson told Fox News Digital. "Even after my husband sent a prevention letter explaining our health plan overseas, they still denied us."
Read On The Fox News App
Official Navy policy under BUMEDINST 1300.2B is clear: "Family members are not required to be immunized."
Similarly, TRICARE, healthcare for uniformed service members, explicitly states that "vaccination status is not reviewed as part of the TRICARE overseas enrollment screening process." And the Johnsons' destination, Peru, does not require any vaccinations for entry or residence.
Former Air Force Major Who Defied Biden Vaccine Mandate Speaks Out, Applauds Hegseth
"We're not breaking any rules. Peru doesn't require vaccines, and Navy policy doesn't either," Johnson said. "We've done everything right, but, still, we're stuck.
"My husband's chain of command supports us and keeps asking, 'Who do we need to call?' But there's no one. No officer has ever called us from Navy Medical. We haven't worked with a single point of contact on our case."
Marine Capt. Hunter Johnson, Amanda's husband, wrote a detailed prevention and medical readiness letter to Navy Medical Jacksonville, outlining the measures his family takes to maintain their children's health.
"Our children have not been, and will not be, enrolled in childcare. My wife is fully devoted to their daily care," he wrote. "We homeschool using Time4Learning and limit exposure to institutional illness risks.
"Peru has no vaccination requirements... My continued presence is essential to our family's stability. This is not a deployment, it's a PCS [permanent change of station]."
Despite that, Amanda Johnson says Navy Medical Jacksonville denied the package and falsely claimed last month it had been sent to Naval Medical Atlantic Region for final review.
The stress has deeply affected their family. Johnson shared that her husband delayed his paternity leave to avoid being recycled through his language course.
"He went back to work five days after I had our fifth baby. Now, during his leave, instead of relaxing, he's chasing paperwork and dealing with this nightmare," she said.
They've already secured housing in Peru and booked an Airbnb near Los Angeles International Airport as they prepare for their flight.
"They told us, 'You can push out your orders,' but that's absolutely not an option. We're not going to be punished because Navy can't get it together," she said.
The family filed a congressional inquiry through the office of Rep. Jim Jordan, R-Ohio. Johnson also confirmed that the office of Rep. Chip Roy, R-Texas, reached out after seeing her story on Instagram.
"My husband had a phone call with them and explained everything. I'm not from Texas, but they saw the post and wanted to help," she said. "It's a big, big mess."
Johnson said she isn't just asking for her own family to be cleared. She wants reform.
"I want whoever denied our package to be held accountable. There should be consequences. The policy is clear, and they're ignoring it," she said. "No doctor in the Navy should be allowed to declare a child unsuitable for travel just because of their vaccine status. That needs to end."
She said she hopes her story sparks wider change.
"Vaccination status is no one's business, especially for dependents. I hope the Navy stops asking altogether unless the host country requires it. We're being punished for nothing."
The Department of the Navy did not immediately respond to Fox News Digital's request for comment.Original article source: Military spouse and mom of 5 fights back as vaccine dispute blocks family's permanent change of station

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

BioNTech to Acquire CureVac in Stock Deal Valued Around $1.25 Billion
BioNTech to Acquire CureVac in Stock Deal Valued Around $1.25 Billion

Yahoo

time33 minutes ago

  • Yahoo

BioNTech to Acquire CureVac in Stock Deal Valued Around $1.25 Billion

BioNTech will acquire all shares of CureVac after the two sides reached an agreement in a deal valued around $1.25 billion. Each share of CureVac, a clinical-stage biotech company, will be exchanged for about $5.46 in BioNTech American depositary shares. Upon the deal's closing, CureVac shareholders are expected to own between 4% and 6% of the German developer of RNA vaccines and immunotherapies. ICE Raids Have Sent Latino Shoppers Into Hiding and Big Brands Are Hurting The Secret to Retaining the Best Employees: Ask Them These Four Questions Here's How Much Money the U.S. Is Earning From Tariffs, in Charts How Home Depot Became Ground Zero in Trump's Deportation Push Supply Chains Become New Battleground in the Global Trade War BioNTech Chief Executive Ugur Sahin said the plan is to bring complementary capabilities between the two companies together to develop transformative cancer treatments. CureVac's operating subsidiary will become a wholly owned subsidiary of BioNTech following the close of the transaction. As part of this plan, BioNTech will integrate CureVac's research and manufacturing site in Tübingen, Germany. The deal was unanimously approved by both companies' management and supervisory boards. It is expected to close in 2025. Shares of CureVac surged 29% to $5.25 in premarket trading. Write to Denny Jacob at Pulls Outlook as Sales Fall Bojangles Is Exploring a Sale While the Fried-Chicken Market Is Hot Why Bosses Should Give Feedback in the Morning The Audacious Reboot of America's Nuclear Energy Program Muted May Inflation Defies Tariff Fears Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Is Fidelity Select Portfolio Medical Technology and Devices (FSMEX) a Strong Mutual Fund Pick Right Now?
Is Fidelity Select Portfolio Medical Technology and Devices (FSMEX) a Strong Mutual Fund Pick Right Now?

Yahoo

time33 minutes ago

  • Yahoo

Is Fidelity Select Portfolio Medical Technology and Devices (FSMEX) a Strong Mutual Fund Pick Right Now?

If you have been looking for Sector - Health funds, a place to start could be Fidelity Select Portfolio Medical Technology and Devices (FSMEX). FSMEX has a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various forecasting factors like size, cost, and past performance. Zacks categorizes FSMEX as Sector - Health, a segment packed with options. Sector - Health mutual funds offer investors a focus on the healthcare industry, one of the largest sectors in the American economy. These funds can include everything from pharmaceutical companies to medical device manufacturers and for-profit hospitals. Fidelity is responsible for FSMEX, and the company is based out of Boston, MA. Fidelity Select Portfolio Medical Technology and Devices made its debut in April of 1998, and since then, FSMEX has accumulated about $4.48 billion in assets, per the most up-to-date date available. The fund is currently managed by Edward Yoon who has been in charge of the fund since May of 2007. Investors naturally seek funds with strong performance. This fund has delivered a 5-year annualized total return of 5.12%, and it sits in the middle third among its category peers. If you're interested in shorter time frames, do not dismiss looking at the fund's 3 -year annualized total return of 3.37%, which places it in the bottom third during this time-frame. It is important to note that the product's returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund's [%] sale charge. If sales charges were included, total returns would have been lower. When looking at a fund's performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. Over the past three years, FSMEX's standard deviation comes in at 18.22%, compared to the category average of 15.64%. Over the past 5 years, the standard deviation of the fund is 19.24% compared to the category average of 16.64%. This makes the fund more volatile than its peers over the past half-decade. Investors should note that the fund has a 5-year beta of 0.92, which means it is hypothetically less volatile than the market at large. Alpha is an additional metric to take into consideration, since it represents a portfolio's performance on a risk-adjusted basis relative to a benchmark, which in this case, is the S&P 500. With a negative alpha of -7.95, managers in this portfolio find it difficult to pick securities that generate better-than-benchmark returns. Costs are increasingly important for mutual fund investing, and particularly as competition heats up in this market. And all things being equal, a lower cost product will outperform its otherwise identical counterpart, so taking a closer look at these metrics is key for investors. In terms of fees, FSMEX is a no load fund. It has an expense ratio of 0.63% compared to the category average of 1.11%. Looking at the fund from a cost perspective, FSMEX is actually cheaper than its peers. While the minimum initial investment for the product is $0, investors should also note that there is no minimum for each subsequent investment. Fees charged by investment advisors have not been taken into considiration. Returns would be less if those were included. Overall, Fidelity Select Portfolio Medical Technology and Devices ( FSMEX ) has a high Zacks Mutual Fund rank, and in conjunction with its comparatively similar performance, average downside risk, and lower fees, Fidelity Select Portfolio Medical Technology and Devices ( FSMEX ) looks like a great potential choice for investors right now. Your research on the Sector - Health segment doesn't have to stop here. You can check out all the great mutual fund tools we have to offer by going to to see the additional features we offer as well for additional information. For analysis of the rest of your portfolio, make sure to visit for our full suite of tools which will help you investigate all of your stocks and funds in one place. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Get Your Free (FSMEX): Fund Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Former MTV VJ and talk show host Ananda Lewis dies at 52

time39 minutes ago

Former MTV VJ and talk show host Ananda Lewis dies at 52

Former television host Ananda Lewis has died, her sister Lakshmi Emory shared in a Facebook post on Wednesday. Lewis was 52. Lewis, who was known for her role as an MTV VJ and host of "Teen Summit," was battling Stage 4 breast cancer. "She's free, and in His heavenly arms," Emory wrote on Facebook. "Lord, rest her soul." Lewis first revealed she was diagnosed with breast cancer in October 2020. She revealed the news in an Instagram video with the hope to encourage other women to get a mammogram. Lewis was battling Stage 3 cancer at the time. "I have been fighting to get cancer out of my body for almost two years," she said at the time. "For a really long time, I have refused mammograms, and that was a mistake." Lewis admitted that she refused regular mammograms because of her fear of being exposed to radiation. People with an average risk of breast cancer are recommended to start mammogram screening starting at age 40 and even younger for those with higher than average risk. Mammograms are considered safe. They emit a very small amount of radiation, but less than a standard X-ray. "I need you to get your mammograms," she implored, sharing that she had to adjust her diet and lifestyle. "I still have a lot of work to do. … I wish I could go back. I have a 9-year-old I need to be here for." In October 2024, a year after her cancer had progressed to Stage 4, Lewis spoke with ABC News' Kelley L. Carter to talk about her diagnosis and the treatment decisions she had to make, which included a refusal to undergo a medically recommended double mastectomy followed by rounds of chemotherapy. "I couldn't handle doing such a drastic surgery in my life at that time," she said. "I was a stay-at-home mom, homeschooling my son. Cancer doesn't come and replace all the other stuff you have to do. Cancer happens on top of your life, and for me, it was just too overwhelming in the beginning." Lewis said at the time that she had opted for homeopathic treatment, including a change in her diet and fractionated chemotherapy, which is not recommended by doctors as effective. Since she revealed her cancer diagnosis, Lewis faced criticism from others for her decision to not have surgery years earlier. "None of those people know me and they don't know the details of my situation," she said. "I'm not gonna sit here and battle people about their opinions. That has no bearing on my life. It's a waste of my time. And I don't have time to waste." "Life owes me nothing," she added. "Every day I get, I'm grateful for. What I do is focus on what I can fix. And what I can control." Lewis, who was born March 21, 1973, in Los Angeles, began her career on BET when she landed a role as host of "Teen Summit" in 1993, a talk show program that focused on issues faced by Black teens. It also included live performances. In 2001, she had her own talk show called "The Ananda Lewis Show." The role that many know Lewis for was as an MTV VJ. She hosted a variety of shows including "Total Request Live" and "Hot Zone." She was a correspondent on "The Insider" from 2004 to 2017. In her 2024 interview with Carter, when asked what she wanted people to remember her by, Lewis said, "That I loved hard and lived loud and didn't back away from problems and loved this life. And was OK with letting it go too." "It's a temporary situation, so do your best," she added. "That's all we're all doing is our best."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store